A Republican Massachusetts lawmaker has filed three new psychedelics reform bills, including proposals to legalize substances like psilocybin and reschedule MDMA pending federal approval while setting a price cap on therapeutic access.
The measures from Rep. Nicholas Boldyga (R), who describes himself as the “most conservative” member of the legislature, are the latest examples of psychedelics reforms that lawmakers in the state are pursuing this session.
“People are suffering from debilitating mental health issues such as PTSD, traumatic brain injury, anxiety, and depression,” Boldyga said in a press release on Tuesday. “These psychedelic compounds and plant medicines are offering hope and healing to those that were once hopeless.”
“Plant medicines have been used for thousands of years by various cultures around the world, they truly are revolutionizing how we approach mental health and wellbeing,” he said.
Here’s what the lawmaker’s psychedelics bills would accomplish:
HB 3589
The legislation would legalize the possession, cultivation and gifting of up to two grams of psilocybin, ibogaine, DMT and mescaline for adults 21 and older.
Boldyga said that the reform is “about ending unjust laws and expanding legal access to lifesaving plant medicines,” adding that it’s important to take a non-commercial approach and not
Read full article on Marijuana Moment